Lupin Limited
Lupin Limited has informed the Exchange regarding a press release dated March 25, 2026, titled “Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets”. |SUBJECT: Press Release
Source link
Lupin Limited has informed the Exchange regarding a press release dated March 25, 2026, titled “Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets”. |SUBJECT: Press Release
Source link